肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

PARD6A通过Serpina3促进肺腺癌细胞增殖和侵袭

PARD6A promotes lung adenocarcinoma cell proliferation and invasion through Serpina3 

原文发布日期:2024-09-19 

英文摘要:

摘要翻译:

原文链接:

文章:

PARD6A通过Serpina3促进肺腺癌细胞增殖和侵袭

PARD6A promotes lung adenocarcinoma cell proliferation and invasion through Serpina3 

原文发布日期:2024-09-19 

英文摘要:

Par6α encoded by PARD6A is a member of the PAR6 family and is reported to promote cancer initiation and progression. PARD6A is frequently upregulated in different types of cancers, but its regulatory role in lung cancer progression is yet to be established. In this study, we analyzed the PARD6A expression in biopsies from lung adenocarcinoma (LUAD) patients, and the survival probability using LUAD tissue microarray (TMA) and online datasets from TCGA and GEO. We conducted in vitro and in vivo assays to assess the role of PARD6A in regulating lung cancer progression, including proliferation, wound healing, transwell, RNA-seq, and subcutaneous tumor mice models. Our findings revealed that PARD6A is highly expressed in cancer tissues from LUAD patients and is associated with poor prognosis in LUAD patients. In vitro assays showed that PARD6A promoted cell proliferation, migration, and invasion. The transcriptome sequencing identified Serpina3 as one of the key downstream molecules of PARD6A. Ectopic expression of Serpina3 rescued impaired proliferation, migration, and invasion in PARD6A-knocking down H1299 cells, whereas silencing Serpina3 impeded enhanced proliferation, migration, and invasion in PARD6A-overexpressing H1975 cells. Our findings suggest that PARD6A promotes lung cancer progression by inducing Serpina3, which may be a promising therapeutic target. 

摘要翻译:

由PARD6A基因编码的Par6α是PAR6家族成员,据报道可促进癌症的发生与发展。PARD6A在多种癌症类型中频繁上调表达,但其在肺癌进展中的调控作用尚不明确。本研究通过肺癌腺癌(LUAD)患者活检样本、组织微阵列(TMA)以及TCGA和GEO在线数据集,分析了PARD6A的表达水平与患者生存概率。我们通过体外和体内实验评估了PARD6A在调控肺癌进展中的作用,包括增殖实验、伤口愈合实验、Transwell实验、RNA测序以及皮下移植瘤小鼠模型。研究结果显示,PARD6A在LUAD患者的癌组织中高表达,且与患者不良预后相关。体外实验表明PARD6A能促进细胞增殖、迁移和侵袭。转录组测序发现Serpina3是PARD6A的关键下游分子之一。过表达Serpina3可挽救PARD6A敲降的H1299细胞中受损的增殖、迁移和侵袭能力,而沉默Serpina3则能抑制PARD6A过表达的H1975细胞中增强的恶性表型。我们的研究结果表明PARD6A通过诱导Serpina3表达促进肺癌进展,Serpina3可能成为潜在的治疗靶点。

原文链接:

PARD6A promotes lung adenocarcinoma cell proliferation and invasion through Serpina3

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……